Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Blanc-Durand

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Bulletin Du Cancer|February 9, 2023
[Immunotherapy in oncogynaecology]Paula Nay, Philippe Morice, Felix Blanc-Durand
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2025
Controversies in the management of clear cell carcinoma of the uterus and ovaryManavi Sachdeva, Felix Blanc-Durand, David Tan
Frontiers in Immunology|January 2, 2024
Targeting the immune microenvironment for ovarian cancer therapyFelix Blanc-Durand, Lai Clemence Wei Xian, David S P Tan
Cancer Treatment Reviews|June 15, 2025
Clearer Horizons: The latest advances in clear cell ovarian cancer treatmentFelix Blanc-Durand, Natalie Ngoi, Diana Lim, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 24, 2024
Updates in the Use of Targeted Therapies for Gynecologic CancersEvelyn Cantillo, Felix Blanc-Durand, Alexandra Leary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2024
Unveiling Commonalities: Exploring Shared Characteristics in Clear-Cell Carcinomas of the Gynecologic TractFelix Blanc-Durand, Natalie Y L Ngoi, Diana G S Lim, et al.
Journal of Gynecologic Oncology|July 24, 2025
Clinical and biological characteristics associated with of loss-of-heterozygosity in endometrial cancerFelix Blanc-Durand, Etienne Rouleau, Patricia Pautier, et al.
Bulletin Du Cancer|March 2, 2023
[Current post-surgical treatment strategies in first-line ovarian cancer]Kaïssa Ouali, Judith Michels, Felix Blanc-Durand, et al.
Bulletin Du Cancer|April 11, 2025
[Intercontinental Multidisciplinary Oncology Videoconferencing between the South Pacific and the French mainland: Reasons for medical evacuation after more than 2000 cases of cancers discussed]Charles Honoré, Nicolas Epaillard, Arthur Geraud, et al.
Biomarker Research|October 20, 2023
Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patientsMaria Kfoury, Reda El Hazzaz, Claire Sanson, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|February 9, 2023
[Immunotherapy in oncogynaecology]Paula Nay, Philippe Morice, Felix Blanc-Durand
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2025
Controversies in the management of clear cell carcinoma of the uterus and ovaryManavi Sachdeva, Felix Blanc-Durand, David Tan
Frontiers in Immunology|January 2, 2024
Targeting the immune microenvironment for ovarian cancer therapyFelix Blanc-Durand, Lai Clemence Wei Xian, David S P Tan
Cancer Treatment Reviews|June 15, 2025
Clearer Horizons: The latest advances in clear cell ovarian cancer treatmentFelix Blanc-Durand, Natalie Ngoi, Diana Lim, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 24, 2024
Updates in the Use of Targeted Therapies for Gynecologic CancersEvelyn Cantillo, Felix Blanc-Durand, Alexandra Leary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2024
Unveiling Commonalities: Exploring Shared Characteristics in Clear-Cell Carcinomas of the Gynecologic TractFelix Blanc-Durand, Natalie Y L Ngoi, Diana G S Lim, et al.
Journal of Gynecologic Oncology|July 24, 2025
Clinical and biological characteristics associated with of loss-of-heterozygosity in endometrial cancerFelix Blanc-Durand, Etienne Rouleau, Patricia Pautier, et al.
Bulletin Du Cancer|March 2, 2023
[Current post-surgical treatment strategies in first-line ovarian cancer]Kaïssa Ouali, Judith Michels, Felix Blanc-Durand, et al.
Bulletin Du Cancer|April 11, 2025
[Intercontinental Multidisciplinary Oncology Videoconferencing between the South Pacific and the French mainland: Reasons for medical evacuation after more than 2000 cases of cancers discussed]Charles Honoré, Nicolas Epaillard, Arthur Geraud, et al.
Biomarker Research|October 20, 2023
Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patientsMaria Kfoury, Reda El Hazzaz, Claire Sanson, et al.
Pageof 2